Now On Air

Liberty #MAGAOne Mix

Via MAGA One Mix

6:00 am 8:00 am


Upcoming shows
Real News

NOW ON AIR
Now On Air

Liberty #MAGAOne Mix

Via MAGA One Mix

6:00 am 8:00 am



Maga First News

Upcoming Shows

Join The MAGA Network on Discord

0 0

Asia shares, bonds buoyed as Fed seen dovish

FILE PHOTO : A man looks at an electronic stock quotation board showing Japan's Nikkei average outside a brokerage in Tokyo
FILE PHOTO : A man looks at an electronic stock quotation board showing Japan's Nikkei average outside a brokerage in Tokyo, Japan, November 13, 2018. REUTERS/Toru Hanai/File Photo

March 18, 2019

By Wayne Cole

SYDNEY (Reuters) – Asian share markets crept ahead on Monday while bonds were in demand globally on speculation the U.S. Federal Reserve will sound decidedly dovish at its policy meeting this week.

Japan’s Nikkei led the way with a rise of 0.7 percent, and MSCI’s broadest index of Asia-Pacific shares outside Japan edged up 0.1 percent.

E-Mini futures for the S&P 500 were just a fraction lower. The S&P 500 boasted its best weekly gain since the end of November last week, while the Nasdaq had its best week so far this year.

There is much talk Fed policymakers will lower their interest rate forecasts, or “dot plots”, to show little or no further tightening this year.

Also expected is more detail on a plan to stop culling the Fed’s holdings of nearly $3.8 trillion in bonds. The two-day meeting ends with a news conference on Wednesday.

As a result, yields on three and five-year Treasuries are dead in line with the effective Fed funds rate, while futures imply a better-than-even chance of a rate cut by year end.

“Long-term bond yields remain noticeably lower across a wide range of countries,” said Alan Oster, group chief economist at National Australia Bank.

“Markets are pricing in little or no chance of a rate hike by the major central banks this year, outside of the Bank of England. The Fed is indicating that it will be patient and we don’t expect any rate hikes this year.”

Data on Friday showed U.S. manufacturing output fell for a second straight month in February and factory activity in New York state hit nearly a two-year low this month, offering further evidence of a sharp slowdown in economic growth early in the first quarter.

A marked decline in Treasury yields has dragged on the dollar, leaving it at 111.55 yen from a top of 111.89 on Friday. Against a basket of currencies, the dollar was pinned at 96.583 having shed 0.7 percent last week.

The euro was holding at $1.1321, well up from the recent trough of $1.1174 which was hit when the European Central Bank took a dovish turn of its own.

Sterling was steady at $1.3292 as markets await some clarity on where the Brexit drama was heading.

British Prime Minister Theresa May’s government is scrambling to get support in parliament for her Brexit deal.

May has only three days to win approval for her deal to leave the European Union if she wants to go to a summit with the bloc’s leaders on Thursday with something to offer them in return for more time.

In commodity markets, spot gold was supported by the widespread decline in bond yields and stood at $1,300.35 per ounce.

Oil prices were near their highest for the year so far. U.S. crude was last off 6 cents at $58.46 a barrel, while Brent crude futures added 2 cents to $67.18.

(Editing by Kim Coghill)

Source: OANN

0 0

Rep. Tim Ryan launches presidential bid, says he can send Trump back to Mar-a-Lago

Touting his ability to win the midwestern states that vaulted Donald Trump into the White House in 2016, Democratic Rep. Tim Ryan of Ohio on Thursday declared his candidacy for the presidency.

“I’m going to run for president of the United States,” Ryan said during an appearance on ABC's “The View.”

RYAN WARNS DEMOCRATS NOT TO BE 'HOSTILE TO BUSINESS'

Ryan, who’s represented much of northeastern Ohio in Congress for nearly two decades, highlighted on his new campaign website his inspiration to launch a presidential bid.

“When our local GM factory was shut down last Thanksgiving, I got a call from my daughter who was consoling her friend whose father was an auto worker and was just laid off. My daughter said to me, with tears in her voice, ‘You have to do something,’” Ryan explained.

Ryan, who describes himself as a "lifelong Rust Belt native," said in his TV appearance that “I can win western PA, I can win Ohio. I can win Michigan. I can win Wisconsin. And that means Donald Trump is going back to Mar-a-Lago (the Florida resort owned by Trump) full time.”

And criticizing his own party, the congressman spotlighted that “we stopped going to rural America. We stopped going to these working-class towns.”

With many of his rivals for the Democratic nomination pushing progressive policies favored by the party’s activist class, Ryan pushed back against the perception that he’s a strictly centrist or moderate politician.

“I’ve got a really long record around progressive politics, especially when it comes to the economy. Voted against the Bush tax cuts. Voted against the Trump tax cuts. Believe in investment into lifting people up, closing the opportunity gaps that exist in our society,” he stressed.

The congressman highlighted that “I’m a progressive who knows how to talk to working-class people and I know how to get elected in working-class districts. Because at the end of the day the progressive agenda is what’s best for working families.”

But in an interview in February with Fox News, Ryan warned that his party has to be “very careful” not to appear too anti-business as it tries to win back the White House.

“I think we’ve got to be very careful. We come off sometimes as hostile to business,” he lamented as he spoke the day after self-proclaimed democratic socialist Sen. Bernie Sanders of Vermont launched his second straight White House campaign.

Asked by Fox News how he’d stand out in a large field of 2020 Democratic contenders including many with bigger names and bigger fundraising figures, Ryan pointed to his experience living in northeast Ohio, where he’s watched “this economic train wreck happen to my family, my friends, my community ... and in 16 years in Congress, I’ve been working extremely hard to rebuild these communities.”

Ryan gained national stature in 2016 as he launched an unsuccessful challenge to unseat Nancy Pelosi as Democratic House leader. The nine-term congressman also was one of the leaders late last year of the failed intra-party attempt to prevent Pelosi returning to the House speakership.

Ryan will formally launch his campaign Saturday in Ohio.

Source: Fox News Politics

0 0

U.S. mortgage requests rise as loan rates hold near 10-month low: MBA

A view of single family homes for sale in San Marcos
A view of single family homes for sale in San Marcos, California October 25, 2013. PROPERTY REUTERS/Mike Blake

February 20, 2019

NEW YORK (Reuters) – U.S. mortgage applications increased for the first time in five weeks as most home borrowing costs hovered near their lowest levels in 10 months, the Mortgage Bankers Association said on Wednesday.

The Washington-based industry group said its seasonally adjusted gauge on loan requests to buy a home and to refinance one rose 3.6 percent to 365.3 in the week ended Feb. 15. The prior week’s reading was the lowest in a month.

(Reporting by Richard Leong)

Source: OANN

0 0

Snell fans 11 as Rays defeat White Sox

MLB: Tampa Bay Rays at Chicago White Sox
Apr 8, 2019; Chicago, IL, USA; Tampa Bay Rays starting pitcher Blake Snell (4) delivers in the third inning against the Chicago White Sox at Guaranteed Rate Field. Mandatory Credit: Matt Marton-USA TODAY Sports

April 9, 2019

Blake Snell allowed one run in six innings and the visiting Tampa Bay Rays continued to match their best start in franchise history with a 5-1 win against the Chicago White Sox on Monday afternoon.

Snell (2-1) gave up six hits while striking out 11 and walking none.

Willy Adames had three hits, a walk and scored two runs in the No. 9 spot, and Avisail Garcia, Daniel Robertson and Yandy Diaz had two hits each for Tampa Bay, which has won eight of its first 11 games for the second time in team history.

Coming into the game, Tampa Bay starting pitchers had not allowed a run in their past 31 innings, and Snell had thrown eight straight shutout innings. He ran that streak to 12 before Jose Rondon hit a solo homer in the fifth to make it 4-1.

White Sox starter Carlos Rodon (1-2) struggled early against the Rays before leaving after 4 2/3 innings, allowing four runs and eight hits with nine strikeouts and five walks on 111 pitches.

After the Rays loaded the bases with no outs in the first inning, Rodon got Garcia to strike out on a pitch outside the zone, but then walked the next batter, Guillermo Heredia, to force in a run.

Ji-Man Choi followed with a sacrifice fly to make it 2-0.

Rodon threw 39 pitches in the first inning before giving up a leadoff double to Adames to start the second. Following a strikeout, walk and double steal, Adames scored on a safety squeeze by Robertson, and Tommy Pham came home on a single by Garcia to make it 4-0.

The White Sox had a runner on third with no outs in the sixth inning, but Snell struck out Jose Abreu, Welington Castillo and Yoan Moncada, the No. 3-4-5 hitters for Chicago.

The White Sox recalled reliever Carson Fulmer from Triple-A Charlotte on Monday and he relieved Rodon, nearly throwing 3 1/3 shutout innings before walking in a run with two outs in the eighth to make it 5-1.

Leury Garcia had three hits to lead Chicago.

–Field Level Media

Source: OANN

0 0

Ahold says on course to meet U.S. online sales growth targets

The Ahold Delhaize logo is seen at the company's headquarters in Zaandam
The Ahold Delhaize logo is seen at the company's headquarters in Zaandam, Netherlands August 23, 2018. Picture taken August 23, 2018. REUTERS/Eva Plevier

February 27, 2019

By Anthony Deutsch

AMSTERDAM (Reuters) – Ahold Delhaize, which operates supermarkets in Europe and the United States, is on track to meet a 20 percent U.S. online sales growth target this year as it opens automated grocery distribution points along the East Coast, its chief executive said on Wednesday.

Frans Muller, promoted to the top job last July, said in an interview that Ahold, which makes roughly two-thirds of its sales in the United States, plans to open several more of the automated hubs in 2019.

The comments came after Ahold said on Wednesday that group net consumer online sales rose 25 percent to 1.1 billion euros in the fourth quarter at constant exchange rates.

In the Netherlands, where it also operates the non-food Bol.com retailer, Ahold saw strong online sales growth of 28 percent. In the U.S., online sales rose 12 percent at constant exchange rates to 203 million euros in the three months through Dec. 31.

Overall, Ahold said its core earnings rose 9.5 percent in the fourth quarter, bolstered by strong online sales growth, meeting market expectations.

Muller has said the company hopes to make acquisitions to meet targets of 20 percent online U.S. sales growth in 2019 and 30 percent in 2020.

“We are on track for 2019 to make our 20 percent. That’s all planned for and I am excited about reaching 30 percent,” Muller told Reuters. “I think the market is there.”

Speaking about acquisitions, Muller said, “we see more opportunities in the U.S. The market is consolidating. We have a strong base and strong brands along the East Coast.”

In November, Ahold announced plans to roll out small, automated warehouses to increase order picking and cut delivery times, part of a revamp of its ecommerce business to help fight competitors like Kroger, Walmart and Amazon.

Muller said several new centers will be opened this year, with a higher number in 2020, but gave no specific number.

Ahold’s underlying income increased to 691 million euros ($786 million) in the three months through Dec. 31, in line with forecasts. Ahold shares slipped 1.8 percent by 0835 GMT.

Ahold, which operates the ‘Stop & Shop’ and ‘Food Lion’ chains in the United States, confirmed its 2019 target of 750 million euros in gross synergies from the merger with Delhaize.

(Reporting by Anthony Deutsch; Editing by Keith Weir)

Source: OANN

0 0

Texas mom, 28, abandoned 5 kids to take trip to Myrtle Beach, SC, police say

A Texas mother has been charged with child abandonment for leaving her five children at home alone for several days while she traveled to South Carolina last summer, according to an arrest affidavit released Tuesday.

Chrystal Nichole Walraven, 28, of Round Rock, was arrested Feb. 11 on two counts of abandoning or endangering a child, which is a second-degree felony, according to a report.

The children ranged in age from 15 months to 12 years, the Austin American-Statesman reported.

Walraven traveled to Myrtle Beach to investigate a job opportunity and "because she needed to get away from everything that was happening at home," the paper reported, citing an affidavit.

SINGLE MOM 'TIRED OF DOING THIS BY MYSELF' ABANDONED 2 KIDS BY ROADSIDE, AUTHORITIES SAY

She had also gone to the beach and visited tourist locations while staying with a male friend, according to the affidavit.

Round Rock Police told Fox 7 Austin they visited Walraven's home in late August after the Gattis Elementary School principal expressed concern about a student's living situation.

Walraven's children complained to the principal about having to stay up all night to change their younger sibling's diapers, the station reported, citing court documents.

Police, after visiting the home, reported that it smelled like garbage and feces, Fox 7 reported.

The officers said there was an infant in a crib near the front door, with four other children found home alone, according to the station.

Officers also found a dirty diaper in a closet, stains on the carpet, flies in the kitchen and multiple knives that the children could access, the American-Statesmen reported, citing an affidavit.

CLICK HERE TO GET THE FOX NEWS APP

Officers called Child Protective Services, Fox 7 reported. The children were initially placed in foster care, but are now living with relatives, Marissa Gonzales, a spokeswoman for the Texas Department of Family and Protective Services, told the American-Statesmen.

If convicted, Walraven faces 2-20 years in prison, according to Fox 7.

Source: Fox News National

0 0

Medical Alert: Hospitals Are Releasing Deadly Superbug Fungi Into The Open Air, “Colonizing” The Population With Dangerous Pathogens That Have A 41% – 88% Fatality Rate

Imagine a dystopian science-fiction future where hospital ventilation systems are pumping out a deadly superbug, right into the open atmosphere, where winds carry it to local communities and farms, infecting crops and foods with chemical-resistant fungal strains that have a reported 41% – 88% fatality rate in humans.

And imagine the CDC knew about it, but refused to tell you which hospitals were infected. Local hospitals hid the fact that their own hospital rooms and intensive care units were being overrun with this fatal fungi, and that all the world’s epidemiological experts had no idea where the pathogen had come from or how to stop it.

But they all kept it a secret, because they didn’t want to “alarm” the public. And they sure didn’t want hospitals to be seen as hubs of superbug infections.

Well, imagine no more. This is real. It’s happening right now. And this pandemic has been silently spreading over the last four years, with virtually zero media reports, very little information from the CDC, and a coordinated cover-up by the hospitals of the western world to keep patients in the dark while they’re being infected and killed by a deadly pathogen.

This is the true story of Candida auris, a superbug fungal strain that has emerged from the widespread use of chemical fungicides in agriculture. In this extended Natural News report — initially based on a New York Times report but significantly expanded — you will learn why this silent pandemic has already invaded America’s hospitals and why it cannot be stopped using any known medical defense. It may already be too late for the planet. By abusing agricultural chemicals, humanity has given rise to a superbug that could, under the right conditions, kill a billion people and collapse the entire western medical system.

And you may already be “colonized” by this fungus, serving as a carrier who will infect others in your own family and community.

How did this happen? Understanding Candida auris

According to a bombshell New York Times investigation — yes, even the New York Times occasionally commits acts of real journalism — this pandemic has already found its way into some of the largest hospitals in New York, Chicago and London. The superbug fungus has spread to nursing homes and is carried from patient to patient by health care workers. It grows on IV lines and ventilators, and it infects hospital gowns and clothing. Aggressive sterilization efforts using aerosolized hydrogen peroxide do nothing to kill this fungus, and the cover-up continues, even as rates of infections and fatalities are exploding across the western world.

The fungus is called Candida auris, or C. auris for short. It’s called Auris because it was originally discovered to be living in a woman’s ear in Japan. But now, it has spread to every continent, and its rise has only been made worse by a coordinated cover-up by the CDC, hospitals and the corrupt medical industry that places its own profits over the safety of the public. If there were a vaccine for Candida auris, these infections would be front page news across the globe, and journalists would be screaming at everyone to get injected with the vaccine. But since the medical establishment has no treatment whatsoever for this deadly pathogen, they’ve conspired to cover it up.

This Natural News report aims to explain how this happening and how the science lies of the chemical agricultural giants have now put the entire human race at risk from this exploding superbug pathogen.

To understand how we got here, we have to go back a few years and take a closer look at fungi that grow naturally in crop soils.

The mass chemical contamination of farm soils in the name of “crop yields”

Soil is a complex living ecosystem, and soils naturally harbor an astonishing array of microbiology, including bacteria, fungi and viruses. In healthy soils, the most dangerous organisms are crowded out by good organisms. This survival competition keeps the really nasty bugs in check, preventing them from expanding their colonies and gaining ground.

But modern farming relies heavily on chemical pesticides, herbicides and fungicides. These chemicals, which are routinely sprayed on food crops, demonstrate selective chemical toxicity that kills some organisms but leaves others untouched. Even worse, some strains develop resistance to agricultural chemicals through a process of adaptation and microbiological natural selection. This leads to the rise of so-called superbugs. (See Superbugs.news for more reports.)

“Superbugs” is a generic term that can apply to insects that develop chemical resistance, or it can describe microbes and even fungi that develop resistance to chemicals that would otherwise kill them. Any organism that survives the onslaught of toxic chemicals and develops a physiological survival mechanism to nullify or eliminate those chemicals will suddenly find itself able to grow and spread at a ferocious rate. That’s because its competition has been wiped out by the agricultural poisons such as fungicides. So as farmers sprayed fungicides on virtually every vegetable and fruit crop in existence, this practice led to the inevitable rise of a superstrain of Candida auris, which now finds itself able to replicate and spread in ways that never could have been possible when all the other fungi were competing for the same resources.

Killing off the “good” fungi, in other words, allowed the really dangerous fungal strains to succeed like never before. And the more chemicals are sprayed on food crops, the more dangerous the pathogens become. This is all caused by human intervention via chemical agriculture — an artificial way to produce food for the masses.

Millions of tons of fungicides are sprayed on food crops every year in the United States alone

By 2023, it is estimated that annual expenditures on fungicides will reach $21 billion worldwide. In 2016, an average of 4.26 pounds of fungicide chemicals were applied per acre in the United States, and one of the largest classes of fungicide chemicals is called “azole fungicides.”

Azole fungicides now account for one third of global sales of fungicides, and various derivatives of azoles are heavily applied to crops every day, all over the world, including triazoles and benzimidazoles. These chemicals end up not merely in our food, but in agricultural runoff, eventually contaminating water supplies, rivers and even oceans. Over time, as these azole chemicals were repeatedly applied to food crops year after year, Candida auris developed robust immunity to these chemicals, enabling the fungus to survive on food crops due to the fact that it now had no competition, since most other fungi strains were killed by the chemicals.

So crops harvested from food fields carried this fungus to food markets and grocery stores. There, consumers purchased the products and prepared them at home, touching those fruits and vegetables with their bare hands and transferring the fungal colonies to their homes, their clothing and other family members. Almost instantly, Candida aurisspread from foods to home environments, persisting in damp kitchens, dark drawers and closets, effectively colonizing humans who then carried it to other humans.

From here, it was only a matter of time before C. auris found its way to hospitals, nursing homes, surgical centers and retirement centers. Today, C. auris is no doubt colonizing children in day care centers; co-workers in office environments; friends at social gatherings and family members at holiday events.

Everything in hospital rooms is infected: The bed rails, window shades, curtains, doors, bed and even the ceiling

When a man died at Mount Sinai hospital in Brooklyn after being infected with C. auris, his hospital room was tested for the pathogen, reports the New York Times:

“Everything was positive — the walls, the bed, the doors, the curtains, the phones, the sink, the whiteboard, the poles, the pump,” said Dr. Scott Lorin, the hospital’s president. “The mattress, the bed rails, the canister holes, the window shades, the ceiling, everything in the room was positive.”

The fungus preys on those with weakened immune systems, including infants and the elderly. Its symptoms include extreme fatigue, and in certain immune-weakened populations, it has so far been observed to kill 41% of those it infects. (See below for more statistics showing an even higher fatality rate.)

People with strong immune systems are apparently able to fight off the effects of the fungus, but even if they show no symptoms, they may be carriers of the strain, infecting others who may suffer from weakened immune function. This includes infants and seniors, but can also impact those who have caught a cold or a flu, or even people who have endured an extremely strenuous workout at the gym, placing themselves in an immunosuppressed condition for 2-3 days. “[T]hey are most lethal to people with immature or compromised immune systems, including newborns and the elderly, smokers, diabetics and people with autoimmune disorders who take steroids that suppress the body’s defenses,” the NYT explains.

It is self-evidence that C. auris will also attack those who are taking antibiotics, as their own personal gut flora are wiped out by the antibiotic drugs in exactly the same way that friendly fungi are wiped out across crop fields by azole fungicide chemicals. Thus, the people who undergo surgical procedures at hospitals and are routinely given antibiotics as part of the treatment are also being kept in the very same hospital rooms where Candida auris is increasingly festering.

This combination is a public health catastrophe waiting to happen. Hospitals have now become colonization centers where humans are exposed to deadly fungi. Hospitals, in a very real sense, are spreading the pandemic. Again, from the NYT:

[T]he germs are easily spread — carried on hands and equipment inside hospitals; ferried on meat and manure-fertilized vegetables from farms; transported across borders by travelers and on exports and imports; and transferred by patients from nursing home to hospital and back.

Five warnings from the CDC’s fungal expert, Dr. Tom Chiller

The CDC’s own chief of its fungal research division, Dr. Tom Chiller, warns about Candida auris, “behaving in unexpected and concerning ways, causing severe disease in countries across the globe, including the United States.” In a Medscape article published in 2017, Dr. Chiller lays out some facts about Candida auris that even the New York Times decided not to report. Via Dr. Chiller’s warning: (my comments are added in parenthesis)

Warning #1) C auris can spread between patients in healthcare facilities and cause outbreaks. In this way, it appears to behave much like some multidrug-resistant bacteria (eg, methicillin-resistant Staphylococcus aureus or Acinetobacter).

Warning #2) C auris can colonize a patient’s skin for months or longer. (Yes, months. That means carriers can remain carriers for a very long time.)

Warning #3) This hardy yeast can live on surfaces for a month or more, and preliminary testing suggests that quaternary ammonium compounds commonly used for healthcare disinfection may not be sufficiently effective against C auris. (In other words, the usual chemicals that hospitals use to clean rooms simply don’t work against Candida auris.)

Warning #4) C auris is quickly becoming more common. In some international healthcare facilities, it has gone from an unknown pathogen to a cause of 40% of invasive Candida infections within a few years. We need to act now to prevent this from happening in the United States. (Too late. It’s also endemic in U.S. hospitals in Illinois, New Jersey and New York, although the CDC refuses to tell us which hospitals have been colonized by the fungus.)

Warning #5) C auris is often multidrug resistant. Some strains have been resistant to all three major antifungal classes, including echinocandins, the first-line treatment for Candida infections.

But it’s far worse than all that, in reality. Candida auris is airborne, and it floats through the air inside hospitals, infecting patients, hospital staff and colonizing hospital rooms and surgical areas. Even worse, the deadly pathogen is now escaping hospitals and infecting surrounding communities. Hospitals have, in effect, become hubs for spreading this deadly superbug across the country and around the world.

“Aerial samples of hospitals” test positive for the deadly pathogen… hospitals are factories that churn out this deadly disease

In 2013, a published science paper examined the spread of azole-resistant Aspergillus fumigatus arising from the agricultural use of azole fungicides. The paper was published in PLOS Pathogens with the title, “Emergence of Azole-Resistant Aspergillus fumigatus Strains due to Agricultural Azole Use Creates an Increasing Threat to Human Health.”

The paper supports the astonishing conclusion that people are acquiring fungicide-resistant strains through “environmental sources” rather than experiencing fungal mutations in their own bodies while being treated with anti-fungal drugs. As the study explains:

Several recent findings support the hypothesis that ARAF (azole-resistant A. fumigatus) strains in patients with invasive aspergillosis were more likely to be acquired from environmental sources rather than from de novo mutation and selection within patients during azole therapy.

The supporting evidence for this extremely disturbing realization is also cited by the science paper as follows:

#1) “ARAF strains have been found in patients who had never been treated with azole antifungal drugs.”

#2) “ARAF strains have been found in many environmental niches including flowerbeds, compost, leaves, plant seeds, soil samples of tea gardens, paddy fields, hospital surroundings, and aerial samples of hospitals.” This means that hospitals are effectively pumping out the fungal strains to surrounding areas.

#3) “These strains showed cross-resistance to voriconazole, posaconazole, itraconazole, and to six triazole fungicides used extensively in agriculture.” In other words, the fungus is almost certain to have emerged from repeated exposure to agricultural fungicides, since those are the chemicals for which it has developed innate resistance.

As the paper explains, it is the agricultural use of azole fungicides that supplies the most likely explanation for fungicide-resistant superbug fungi:

For example, azole fungicides are broadly used to control mildews and rusts of grains, fruits, vegetables, and ornamentals; powdery mildew in cereals, berry fruits, vines, and tomatoes; and several other plant pathogenic fungi. Over one-third of total fungicide sales are azoles (mostly triazoles) and over 99% of the DMIs (demethylase inhibitors) are used in agriculture. In addition, there are over 25 types of azole DMIs for agricultural uses, far more than the three licensed medical triazoles for the treatment of aspergillosis. Furthermore, the azoles could persist and remain active in many ecological niches such as agricultural soil and aquatic environments for several months.

The widespread application of fungicide for agricultural use, in other words, is the credible, rational explanation for the widespread development of azole-resistant fungi strains that colonize and kill people, including people who have never been known to carry the non-resistant strains in the first place.

Azole-resistant Aspergillosis killed human patients with a mortality rate of 88%

One of the most horrifying findings of scientists who study azole-resistant fungi is the startlingly high mortality rate. Azole-resistant Aspergillosis was found to kill 88% of patients who were infected. As the PLOS Pathogens study cited earlier describes:

In fact 50% of the patients with invasive aspergillosis due to ARAF are known to be azole naïve and the outcome of patients with azole-resistant invasive aspergillosis has been dismal, with a mortality rate of 88%. (Van der Linden JWM, Snelders E, Kampinga GA, Rijnders BJA, Mattsson E, et al. (2011) Clinical implications of azole resistance in Aspergillus fumigatus, the Netherlands, 2007–2009. Emerg Infect Dis 17: 1846–1852.)

Even more alarmingly, it looks like patients currently being diagnosed as having chronic pulmonary infections may actually be victims of azole-resistant fungal infections. As the study explains, the genetic analysis (via PCR) of tissues from patients suffering chronic lung infections found that over half showed mutations characteristic of azole-resistant fungal strains:

[T]he same mechanism has also been reported in patients with chronic and allergic pulmonary infections [20]. For example, Denning et al. detected TR34/L98H and M220 mutations in 55.1% respiratory samples of CPA and ABPA patients by direct PCR…

This same genotype was, “found in 90% of ARAF isolates obtained from azole-naïve patients,” the study reports, meaning it’s a near-certain sign that these patients have been colonized by azole-resistant fungal strains.

Chemical agriculture has unleashed a deadly global pathogen with no known medical treatment… and the entire medical establishment is burying the truth while exposing millions of hospital patients every day

The upshot of all this is that chemical agriculture has given rise to a deadly global pathogen that has spread across the globe and has no known medical treatment. The NYT article quotes Dr. Lynn Sosa, the deputy state epidemiologist for Connecticut, saying, “It’s pretty much unbeatable and difficult to identity.” That story adds that nearly 50% of patients who contract Candida auris are dead within 90 days, according to what appears to be reluctant statements from the CDC. There, the head of the fungal research branch, Dr. Tom Chiller, described the fungal superbug as “a creature from the black lagoon,” the NYT reported. “It bubbled up and now it is everywhere.”

Except that it didn’t have to be that way. There has been a cover-up for years. The very medical establishment that is entrusted with keeping people safe from deadly pathogens has, itself, become both the distribution hub for spreading the disease while simultaneously colluding with the CDC to hide the truth about all this from the public. It is the hospitals that are now “fungal factories” which are spreading the disease, literally releasing superbug pathogens into the open air, contaminating entire communities with fungal spores that are stronger than any treatment chemical known to western medicine.

There simply is no treatment, no cure, and very little honesty about the reality of the situation. To his credit, the CDC’s Dr. Chiller did post a warning about all this in 2017, but the CDC itself has refused to name the hospitals where these outbreaks are taking place.

The NYT describes the bizarre combination of panic and collusion that’s now taking place in hospitals across the world:

In late 2015, Dr. Johanna Rhodes, an infectious disease expert at Imperial College London, got a panicked call from the Royal Brompton Hospital, a British medical center outside London. C. auris had taken root there months earlier, and the hospital couldn’t clear it.

“‘We have no idea where it’s coming from. We’ve never heard of it. It’s just spread like wildfire,’” Dr. Rhodes said she was told. She agreed to help the hospital identify the fungus’s genetic profile and clean it from rooms.

Under her direction, hospital workers used a special device to spray aerosolized hydrogen peroxide around a room used for a patient with C. auris, the theory being that the vapor would scour each nook and cranny. They left the device going for a week. Then they put a “settle plate” in the middle of the room with a gel at the bottom that would serve as a place for any surviving microbes to grow, Dr. Rhodes said.

Only one organism grew back. C. auris.

It was spreading, but word of it was not. The hospital, a specialty lung and heart center that draws wealthy patients from the Middle East and around Europe, alerted the British government and told infected patients, but made no public announcement.

“There was no need to put out a news release during the outbreak,” said Oliver Wilkinson, a spokesman for the hospital.

This hushed panic is playing out in hospitals around the world. Individual institutions and national, state and local governments have been reluctant to publicize outbreaks of resistant infections, arguing there is no point in scaring patients — or prospective ones.

Now it’s in America… and it’s silently spreading while doctors, hospitals and the CDC are still hiding important facts from the public

According to the CDC, a total of 617 cases of Candida auris have been reported so far in the United States. This is detailed on the CDC’s Candida auris page, which warns that C. auris has “caused outbreaks in healthcare settings,” meaning hospitals and nursing homes are now spreading the superbug pathogen in America.

The CDC’s “tracking” page for Candida auris warns that hospitals around the world are spreading the disease, specifically naming the following countries as locations where healthcare-related pathogen transmission has been reported:

India, Kenya, Kuwait, Pakistan, South Africa, the United Arab Emirates, and Venezuela

Outside hospitals, multiple cases of Candida auris are currently being tracked by the CDC and have been recorded in the following countries:

Australia, Canada, China, Colombia, France, Germany, India, Israel, Japan, Kenya, Kuwait, Oman, Pakistan, Panama, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, the United Kingdom, the United States (primarily from the New York City area, New Jersey, and the Chicago area) and Venezuela

The CDC even warns that hospitals are spreading the disease, saying, “in some of these countries, extensive transmission of C. auris has been documented in more than one hospital.”

Illinois, New York and New Jersey are the hubs for Candida auris infections in U.S. hospitals and healthcare facilities

Candida auris is rapidly spreading across the United States, and the CDC publishes a chart with state-by-state statistics on where the infections are being found, even while refusing to tell the public which hospitals are infected:

https://www.cdc.gov/fungal/candida-auris/tracking-c-auris.html

Currently, the CDC’s tracking page shows 144 infections recorded in Illinois, 104 in New Jersey and 309 in New York. Twelve cases have been reported in Florida, 7 in Massachusetts with a smattering of isolated reports from California, Texas, Virginia and Connecticut.

Importantly, the CDC is so far refusing to name the hospitals or nursing homes where these cases are being found. This means the CDC, as usual, is hiding the truth about a deadly outbreak from the public. This behavior by the CDC will obviously lead to even more people being infected by visiting the hospitals where Candida auriscolonization is already complete. But the CDC seems more interested in protecting the profits of hospitals than in protecting the public from a deadly superbug pathogen, so it looks likely that the secrecy will continue.

Alarmingly, even the CDC says the numbers it has so far published coming out of Illinois, New Jersey and New York are only just the beginning. “Beyond the clinical case counts reported above, an additional 1056 patients have been found to be colonized with C. auris by targeted screening in seven states with clinical cases,” the CDC says. Yet to no one’s surprise, the CDC refuses to name which seven states.

Death by secrecy

Being “colonized” with Candida auris means you’re carrying it, spreading it to other people even though you may not show any symptoms yourself. As the CDC explains, “Colonization means that these patients are found to be carrying C. auris on their bodies, even though they are not sick with the infection.”

If there are 1,056 people across seven states who have already been found to be colonized with Candida auris, it means we are way beyond the Ebola scenario that scared the nation a few years ago when the geniuses at the CDC brought an Ebola patient to a Texas hospital, where that patient promptly spread Ebola to at least one nurse, causing a nationwide panic over a viral outbreak that thankfully failed to explode across the U.S. heartland. But Candida auris has already exploded across America, and the early numbers are only a hint of the scope of the real problem, given that “colonization screening” hasn’t even begun to encompass all of America’s cities or states.

With the CDC hiding the names of the hospitals where this deadly pathogen is spreading — and with the continued heavy application of azole-class fungicides on agricultural products across the country — it seems we’re already at a stage-six pandemic that has only just begun to be fully realized. It’s as if we’re all sailing on the Titanic, and the ship is already 80% under water by the time we realize something’s wrong. This pathogen is already endemic in America.

It’s likely that nearly every hospital, nursing home, public school and day care center in America is already colonized with Candida auris (or will be soon). No person can visit any hospital or healthcare facility without the reasonable expectation of being exposed to this superbug fungal strain, meaning that every visit to the hospital is now a potential death sentence, especially given the 41% – 88% fatality rates that have so far been associated with azole-resistant fungal strains.

Why Western medicine will ignore the obvious solution: Ultraviolet light

What’s even more horrifying about all this is that no one in the western medical system seems capable of thinking outside the realm of chemical treatments, so they all miss the obvious solution: Ultraviolet light. UV light — which everyone can get for free from the sun — kills nearly all fungi and viral strains. But hospitals, nursing homes and other healthcare facilities are unnatural places, characterized by artificial light and dark, damp hallways and rooms. Hospitals are breeding grounds for fungal colonies, and combined with the disturbingly high failure rates of hand washing among health care staff, it is inevitable that azole-resistant fungal strains will colonize every hospital in America over the next several years.

With window shades drawn to keep out the light, hospitals will try to fight the fungus with yet more chemicals, ultimately breeding even more dangerous, drug-resistant strains that could one day bring the world’s western health care system to a grinding halt.

Until that day comes, hospitals across America and around the world are pumping out billions of fungal spores into the open air, contaminating soils, streets and buildings in the surrounding communities. Even being near a hospital makes you a likely victim of fungal colonization. And just like the vaccine holocaust that maims and kills children all across America, the pharma-controlled media will no doubt bury this pandemic and decry those who warn about it as “conspiracy theorists.”

The fact that the New York Times even reported on this is practically a six-sigma event, but it’s an outlier, not the new rule. When health care dollars are at stake, journalism quickly folds to the profit interests of powerful corporations. Soon, the very mention of Candida auris will be decried as “anti-science,” and the World Health Organization will warn that “scare stories” about the superbug fungus are preventing people from visiting doctors and hospitals, thereby interfering with global health care. (This is exactly what the W.H.O. has done to vaccine skeptics who dare talk about the health risks of toxic vaccine ingredients such as squalene or aluminum-based adjuvants.)

Not long after the censorship crackdown on the “Candida conspiracy quacks,” the CDC will scrub its own website of any mention of the pathogen, just like the CDC deleted all its web pages that once admitted 98 million Americans were exposed to cancer viruses found contaminating polio vaccines. Western medicine isn’t good at solving health problems, but it’s very good at covering them up.

Remember: Rockland County, NY recently declared a state of emergency over a handful of measles cases. Yet a deadly fungal pathogen that now threatens to colonize and overrun every hospital and nursing home in the country gets almost zero mention anywhere. It’s clear that government officials and media propagandists have no real interest in protecting public health, but they have a huge interest in promoting the financial interests of the pharmaceutical industry.

Conclusion: Chemical agriculture has already killed humanity… it’s too late to stop this

Five years ago, I warned that chemical agriculture was going to lead to humanity’s destruction. I was attacked and vilified by several science publications, of course, and labeled an “anti-science” nut case. In the years since, I launched what has now become a multi-million dollar ISO-accredited laboratory facility (CWClabs.com); I co-authored a peer-reviewed science paper published in the LC/GC chromatography journal; I launched a book — “Food Forensics” — that achieved a No. 1 science book ranking on Amazon.com; and I was awarded two scientific patents by the U.S. Patent and Trademark Office:

Patent #1) Cesium Eliminator, an invention for removing radioactive cesium-137 isotopes from the human digestive tract. (See Google patents link here.)

Patent #2) Heavy Metals Defense, an invention that removes toxic heavy metals from foods or liquids that are consumed by people or animals. (See Google patents link here.)

Also during those years, juries in California have now twice confirmed that glyphosate herbicide causes cancer, meaning that the U.S. food supply is heavily saturated with a deadly chemical that kills people. Using triple quad mass spec analysis, my laboratory has developed and validated a method for the quantitation of glyphosate in food and water, and we’re using that method to investigate retail food items sold at grocery stores across America. (Our science paper describing this method will soon be submitted for publication in science journals.)

In nearly every fresh food sample we test, we find fungicide chemicals. We also find traces of glyphosate in a fair number of samples (cereals, grains, beer, wine, beans, legumes, etc.), and we find shockingly high levels of lead and cadmium in many superfoods, dietary supplements and nutritional products.

With the Candida auris pandemic now confirmed by the New York Times, the last five years have confirmed that my original warning was correct. Agricultural chemicals are killing humanity; and we’ve only just begun to understand the vectors of emerging pathogens that have now turned virtually the entire global health care system into a suicide mission from the point of view of patients.

Agricultural chemicals don’t even have to kill us directly to be an apocalyptic threat to humanity, you see: They merely have to give rise to deadly pathogens that invade, colonize and infect every hospital, nursing home, subway station, public transport bus, mall, movie theater, church and synagogue across America. It is those pathogens that carry out the killing, not the original agricultural chemicals that gave rise to their existence.

In essence, chemical agriculture has spawned what Dr. Tom Chiller of the CDC calls, “a creature from the black lagoon.” In Dr. Chiller’s own chilling words, he summarizes what I’ve been trying to warn humanity about for fifteen years: “It bubbled up and now it is everywhere.”

And Big Pharma has no answers, no treatment and no cure. The real answer is, quite literally, sunlight. Yet the drug giants can’t patent the sun or charge royalties on it, so sunlight will never be mentioned by the establishment as the most obvious and powerful weapon for eradicating this insidious pathogen.

Meanwhile, hospitals across America will continue serving toxic food and administering toxic drugs to their patients, reveling in the repeat business that comes from the ongoing sickness and suffering that now characterizes western civilization’s chemical approach to everything.

“Better living through chemistry” has now collapsed into tragedy. The future we now face is, “The chemically-induced suicide of the human race.”

That’s the true story of how agricultural fungicides transformed every hospital visit into a suicide mission. If the food doesn’t kill you first, the visit to the doctor surely will.

Source: InfoWars

NOW ON AIR
Now On Air

Liberty #MAGAOne Mix

Via MAGA One Mix

6:00 am 8:00 am



FILE PHOTO: Jet Airways aircraft are seen parked at the Chhatrapati Shivaji Maharaj International Airport in Mumbai
FILE PHOTO: Jet Airways aircraft are seen parked at the Chhatrapati Shivaji Maharaj International Airport in Mumbai, India, April 18, 2019. REUTERS/Francis Mascarenhas/File Photo

April 26, 2019

By Aditi Shah and Abhirup Roy

NEW DELHI/MUMBAI (Reuters) – The grounding of India’s Jet Airways is turning into a quick windfall and long-term opportunity for international airlines keen to scoop up nearly a million outbound passengers from what was once the nation’s biggest airline.

Jet, which previously had a fleet of around 120 largely Boeing Co planes, was forced to indefinitely halt all flight operations on April 17 after its banks rejected the carrier’s plea for emergency funds.

The carrier’s descent into crisis has benefited international airlines in the form of rising fares and demand, data showed.

Fares from India to cities such as Dubai, London, New York, Singapore and Bali in the first quarter of 2019 rose between 4 percent and 32 percent from a year ago, according to Indian travel portal MakeMyTrip Ltd.

In the peak travel months of May and June, fares to London have spiked as much as 36 percent and tickets to San Francisco are up nearly 20 percent from a year ago, according to data from travel portal Yatra.com.

“For the next three months it’s actually bonanza time for international players,” said Ashish Nainan, a research analyst at CARE Ratings. “At least until the middle of June, the fares are not going to come down.”

Due to rising demand, even before Jet’s lessors grounded planes, carriers such as British Airways, Cathay Pacific Airways Ltd, Singapore Airlines Ltd and United Airlines saw an up to a 27 percent increase in passenger numbers from India in the last quarter of 2018, data from India’s aviation regulator showed. That is the latest period for which the data is available.

India is one of the world’s fastest-growing aviation markets, clocking 15-20 percent domestic growth in recent years. It has long had only two full-service long-haul carriers, state-run Air India and Jet.

Jet is now hoping to be bailed out by a new investor, with final bids due on May 10.

INCREASING CAPACITY

Before its grounding, Jet had the biggest share of India’s outbound international air traffic, carrying 12 percent of the 7.8 million passengers headed overseas in the Oct-Dec quarter, down from 14 percent a year earlier, data from the Directorate General of Civil Aviation showed.

For an interactive graphic on Jet’s market share, click https://tmsnrt.rs/2WvDQYi

For an interactive graphic on average daily flights by the airline, click https://tmsnrt.rs/2FeFDel

The total number of passengers traveling overseas with Jet fell 10 percent during the last quarter of 2018 even as the outbound travel market grew about 5 percent.

Meanwhile, Singapore Airlines posted a 27 percent increase in passengers from India, Cathay registered 17 percent growth and British Airways saw a 10 percent rise in the same period.

Cathay said the events at Jet combined with increasing demand for travel had led it to deploy larger aircraft with more seats on some Indian routes.

“In the long term we would certainly like to be able to offer more capacity into India, not just on our existing routes but by establishing new services to secondary cities,” Cathay said in a statement.

Singapore Airlines, in an email to Reuters, said the Indian market is “very promising” but declined to give details of airfare levels or demand patterns in the wake of Jet’s exit, citing a quiet period before the release of its annual results.

DOMESTIC GAINS

Jet’s grounding has also had a big impact on the domestic market, with inter-city air fares to major cities such as New Delhi, Mumbai, Bengaluru and Kolkata soaring more than 20 percent in May and June, according to Yatra.com.

The spike in fares is expected to underpin strong earnings for IndiGo and SpiceJet Ltd, which are set to report results for the quarter ended March 31 in the coming weeks.

“Domestic Indian carriers are the main benefactors, but I suspect if Jet fails to be revived by May 10 then Vistara and other airlines that ply international routes, particularly the lucrative Gulf market, are the main winners,” said Shukor Yusof, the head of aviation consultancy Endau Analytics. Vistara is a joint venture of India’s Tata Sons and Singapore Airlines.

Inadequate bilateral traffic rights between India and other countries, however, could be an impediment to foreign carriers’ hopes of winning business lost by Jet, some analysts said.

“Even before Jet’s operational shutdown, international capacity was significantly constrained,” said Kapil Kaul, CEO for South Asia of consultancy CAPA. “We have now more serious capacity challenge … this is unlikely to be stabilized in the near term.”

A new national government likely to be in place sometime after elections end in May is expected to address the international capacity constraints, and once bilateral agreements are eased airlines including Emirates, Turkish and Qatar would immediately benefit, said Kaul.

“We would love to add more flights but we are at the limit of the allocation granted to us for traffic rights,” Emirates Chief Commercial Officer Thierry Antinori told reporters in Dubai on Wednesday.

(Additional reporting by Alexander Cornwell in Dubai, Jamie Freed in Singapore and Tanvi Mehta in Mumbai; Editing by Muralikumar Anantharaman)

Source: OANN

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the NYSE in New York
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid

April 26, 2019

By Pushkala Aripaka and Ankur Banerjee

(Reuters) – AstraZeneca Plc beat first-quarter sales and earnings expectations on Friday as the British drugmaker benefited from a push into cancer drugs and emerging markets including China.

Newer treatments such as lung cancer drug Tagrisso, now the company’s top selling medicine, have helped the drugmaker’s return to growth after years of crumbling sales due to patent losses on older drugs.

Sales in China have shown explosive growth, more than doubling since 2012, but AstraZeneca executives on Friday said that may not be sustained.

“The enormous growth you currently see in China, 28 percent, probably is not sustainable, but we feel very bullish that the growth will continue to be at a pace of between 15 percent and 20 percent,” Ruud Dobber, executive vice president, BioPharma, told Reuters.

Shares of the company were down 0.2 percent at 5,878 pence at 1031 GMT.

The turnaround in AstraZeneca’s fortunes has been powered by a push into cancer treatments led by Chief Executive Pascal Soriot, who saw off a 2014 takeover bid from Pfizer in part by promising annual sales of $45 billion by 2023.

In the first quarter, sales from its oncology unit rose 59 percent to $1.89 billion, accounting for 35 percent of total product sales.

The company has moved deeper into cancer therapy market through wide-ranging deals, including those for immunotherapy and targeted therapy. Last month, it agreed a multi-billion dollar oncology deal with Japan’s Daiichi Sankyo Co Ltd.

Interactive graphic on AZN’s top 10 drugs by sales – https://tmsnrt.rs/2W5XIRX

“We’re reaching that point where after years of having to keep faith, we have actually got something tangible to believe in,” Hargreaves Lansdown analyst Nicholas Hyett said.

AstraZeneca also backed its annual sales and earnings forecast and said it has extensively prepared for UK’s anticipated exit from the European Union, even in the event of a no-deal exit.

The company has already spent more than 40 million pounds ($52 million) on Brexit preparations, including stockpiling six weeks’ worth of drugs in the UK and four weeks in continental Europe to guard against shortages.

AstraZeneca said product sales rose 14 percent at constant currency to $5.47 billion in the quarter, led by its lung cancer drug Tagrisso and respiratory treatment Pulmicort.

Interactive graphic on AZN’s quarterly oncology sales – https://tmsnrt.rs/2W9tbCD

China sales increased by 28 percent to $1.24 billion in the quarter, accounting for nearly a quarter of overall product sales.

Core earnings came in at 89 cents per share in the quarter. Analysts on average were expecting core earnings of 85 cents per share and product sales of $5.29 billion, according to a company provided consensus of 19 analysts.

(Reporting by Pushkala Aripaka and Ankur Banerjee in Bengaluru; Editing by Bernard Orr/Keith Weir)

Source: OANN

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!

DNA Force Plus

Limited Advanced Release

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

DNA Force Plus

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

DNA Force Plus

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

DNA Force Plus

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

DNA Force Plus

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

DNA Force Plus

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

Source: InfoWars

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!

DNA Force Plus

Limited Advanced Release

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

DNA Force Plus

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

DNA Force Plus

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

DNA Force Plus

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

DNA Force Plus

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

DNA Force Plus

149.95

119.96

DNA Force Plus is finally here! Now you can support optimal energy levels while adapting your body to handle the daily bombardment of toxins to overhaul your body’s cellular engines with a fan-favorite formula.

https://www.infowars.com/wp-content/uploads/2016/02/dna-210.jpg

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

https://www.infowarsstore.com/dna-force-plus.html?ims=jbdoh&utm_campaign=IWL-DNAForcePlus-20%25off-Widget&utm_source=Infowars+Widget&utm_medium=Banner&utm_content=Widget-DNFP-20%25off

Source: InfoWars

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!

It’s the type of crime that doesn’t happen every day.

Police in the suburbs of Philadelphia say three suspects broke into a medical facility in Wynnewood, Pennsylvania, last Saturday and fled with 18 colonoscopies – devices used for examining the health of patients’ colons.

Suspects are seen leaving a medical facility in Wynnewood, Pa., allegedly carrying 18 colonoscopes worth about $450,000. (Lower Merion Police Department)

Suspects are seen leaving a medical facility in Wynnewood, Pa., allegedly carrying 18 colonoscopes worth about $450,000. (Lower Merion Police Department)

AMERICAN SUPERMODEL PAT CLEVELAND ‘STAYING STRONG’ FOLLOWING COLON CANCER DIAGNOSIS

The devices were reportedly worth a total of about $450,000, authorities said.

But police were perplexed about what the suspects might have planned to do with the instruments.

“This is not something that a typical pawn shop might accept,” Lower Merion Police Detective Sergeant Michael Vice told Philadelphia’s WCAU-TV. “My feeling would be that it was some type of black market sales.”

Such a market apparently does exist, Lower Merion Police Superintendent Michael J. McGrath told Philly.com.

CLICK HERE TO GET THE FOX NEWS APP

“They appeared to know precisely where to go, and they pried the door open,” McGrath said of the suspects, who were captured on surveillance video leaving the facility, carrying bulging backpacks.

Police are hoping the suspects will be caught in the end.

Source: Fox News National

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!
Current track

Title

Artist